Pyrazinoate Excretion in the Chimpanzee. RELATION TO URATE DISPOSITION AND THE ACTIONS OF URICOSURIC DRUGS
AUTOR(ES)
Fanelli, George M.
RESUMO
These experiments were designed to define the renal disposition of pyrazinoic acid in a nonhuman primate that is phylogenetically close to man and to relate this to the effects of pyrazinoate on urate excretion. The renal clearance of pyrazinoate was almost always greater than the simultaneous glomerular filtration rate at plasma concentrations ranging from 1.9 to 960 μg/ml. Some inhibitors of tubular secretion, probenecid, MK-282 (an experimental, potent uricosuric drug), p-aminohippurate, iodopyracet, sulfinpyrazone, and mersalyl, reduced clearances of pyrazinoate to values far below filtration rate. Chlorothiazide, allopurinol, and salicylate did not. The clearance of pyrazinoate was not influenced by changes in urine flow. It is concluded that pyrazinoate is actively secreted and actively reabsorbed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=302477Documentos Relacionados
- Gonorrhoea in the chimpanzee. Serological testing.
- Relation between fractional urate excretion and serum triglyceride concentrations.
- The Chimpanzee. Vol. 1. Anatomy, Behaviour and Diseases of Chimpanzees
- Pharmacology of uricosuric drugs.
- Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog renal microvillus membranes.
